HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beatriz Díaz Selected Research

agalsidase beta

6/2021Reduction of agalsidase beta infusion time in patients with fabry disease: A case series report and suggested protocol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beatriz Díaz Research Topics

Disease

1Fabry Disease (Fabry's Disease)
06/2021
1Myocardial Infarction
09/2017
1Ventricular Heart Septal Defects (Ventricular Septal Defect)
09/2017
1Left Ventricular Dysfunction
04/2013
1Heart Failure
04/2013
1Chronic Renal Insufficiency
09/2010
1Malaria
08/2010
1Goiter
05/2007

Drug/Important Bio-Agent (IBA)

1agalsidase betaFDA Link
06/2021
1Calcineurin InhibitorsIBA
09/2010
1PapainIBA
08/2010
1Hemoglobins (Hemoglobin)IBA
08/2010
1Proteins (Proteins, Gene)FDA Link
08/2010
1falcipain 3IBA
08/2010
1Amino AcidsFDA Link
08/2010
1falcipain 2IBA
08/2010
1Cysteine Proteases (Cysteine Protease)IBA
08/2010

Therapy/Procedure

2Therapeutics
04/2013 - 05/2007
1Extracorporeal Membrane Oxygenation
09/2017
1Cardiac Resynchronization Therapy
04/2013
1Heart Transplantation (Grafting, Heart)
09/2010